{"url":"https://newsforagent.com/news/2026-10-26/challenger-rejects-daiichi-life-takeover-bid","markdown_url":"https://newsforagent.com/news/2026-10-26/challenger-rejects-daiichi-life-takeover-bid.md","title":"Challenger Rejects Daiichi Life's A$7.94 Billion Bid","headline":"Challenger Rejects Daiichi Life Unit's A$11.80 Per Share Takeover Bid","description":"Challenger's board rejected TAL Daiichi Life Australia's A$11.80 per share indicative proposal valuing the firm at A$7.94 billion.","section":"Mergers & Acquisitions","published_at":"2026-10-26T00:27:42+00:00","modified_at":"2026-10-26T00:27:42+00:00","author":"News Desk","key_takeaways":["Challenger rejected an indicative proposal from TAL Daiichi Life Australia at A$11.80 per share, valuing the firm at A$7.94 billion.","The board said the proposal is not at a level it could recommend to shareholders and intends to engage with the Japanese insurer.","Daiichi Life Group's offer would buy the remaining 79.5% of Challenger it does not own, valuing that stake at A$6.3 billion."],"companies":[{"name":"Challenger Limited","is_primary":true,"profile_url":"https://akta.pro/company-profiles/0004qnn/challenger-limited","website":"http://www.challenger.com.au"},{"name":"TAL","is_primary":false,"profile_url":"https://akta.pro/company-profiles/02m4ixn/tal","website":"https://asteron.com.au"}],"source":{"publisher":"The future of trading","title":"Australia's Challenger rejects Daiichi Life unit takeover bid, but open to further talks","url":"https://capital.com/en-int/news/australia-s-challenger-rejects-daiichi-life-unit-takeover-bid-but-open"},"other_sources":[],"tags":["Mergers & Acquisitions","Challenger Limited","TAL"],"body_markdown":"[Challenger Limited](https://akta.pro/company-profiles/0004qnn/challenger-limited) said an indicative proposal from [TAL](https://akta.pro/company-profiles/02m4ixn/tal) Daiichi Life Australia Pty to buy more than 79% of its shares is not at a level it could recommend to shareholders. [The future of trading](https://capital.com/en-int/news/australia-s-challenger-rejects-daiichi-life-unit-takeover-bid-but-open) reported that the A$11.80 per share bid values the Australian investment manager at A$7.94 billion, or $5.58 billion.\n\nChallenger is Australia's largest annuities provider and one of its largest active fund managers, offering lifetime and fixed term annuities, aged-care income solutions, and institutional retirement and reinsurance products. TAL Daiichi Life Australia is a unit of Japan's Daiichi Life, which is the parent firm of the Australian insurer.\n\n## Challenger's Board Response to the Daiichi Life Proposal\n\nChallenger said on Monday its board intends to engage with TAL Daiichi Life Australia Pty to see whether a proposal can be reached that the board could recommend. The company said in its statement: \"There is no certainty that the proposal will result in a binding offer or that any transaction will eventuate.\"\n\nEarlier this month, TAL Daiichi Life Australia made the indicative proposal of A$11.80 per share. Daiichi Life, the parent firm of TAL Daiichi Life Australia, did not immediately respond to a Reuters request for comment, according to the report.\n\n## Challenger's Annuity and Reinsurance Operations\n\nChallenger Limited manages more than $124 billion in assets and is Australia's largest annuities provider, according to akta.pro [company records](https://akta.pro/company-data). The group paid about A$5 billion in annuity interest and capital payments to customers in FY25, and about A$6 billion in FY24.\n\nIn May 2026, Challenger completed the acquisition of a $3.62 billion whole-of-loan equipment finance portfolio from Bank of Queensland, expanding the annuity Statutory Fund's interest-earning asset base. The same records show Challenger established Calix Re Limited, a Class E licensed Bermuda reinsurance subsidiary focused on Japan-based fixed term annuities through a long-standing reinsurance partnership, with initial capital provided by Challenger.\n\n## Daiichi Life's Earlier Offer for Challenger\n\nOn October 18, 2026, Bloomberg reported that Daiichi Life Group offered to buy the remaining 79.5% of Challenger Ltd. at A$11.80 per share, valuing the firm at about A$7.9 billion. The offer was roughly 20% above Friday's closing price and valued the stake Daiichi Life does not own at A$6.3 billion.\n\nIn September 2026, AInvest reported that Challenger Limited is buying back up to A$450 million in shares, funded by capital freed from APRA's new solvency framework. The buy-back, plus a dividend raise, reflected the regulator's new rules reducing required capital.\n\n## Next Steps for the Proposal\n\nChallenger said its board intends to engage with TAL Daiichi Life Australia Pty to see whether a proposal can be reached that the board could recommend. The company said there is no certainty that the proposal will result in a binding offer or that any transaction will eventuate.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}